Showing results (1-10 of 384) with videos related to
Sort By:
Pageof 39
Therapeutic Advances in Neurological Disorders|July 19, 2011
Biological outcome measurements for behavioral interventions in multiple sclerosisAnja Fischer, Christoph Heesen, Stefan M GoldNeuroimmunomodulation|August 22, 2007
Stress and disease progression in multiple sclerosis and its animal modelsStefan M Gold, Christoph HeesenBrain and Behavior|October 8, 2015
Diagnostic accuracy for major depression in multiple sclerosis using self-report questionnairesAnja Fischer, Marcus Fischer, Robert A Nicholls, et al.Psychotherapie, Psychosomatik, Medizinische Psychologie|November 10, 2005
[The concept of allostasis and allostatic load: psychoneuroimmunological findings]Karl-Heinz Schulz, Christoph Heesen, Stefan M GoldThe Lancet. Psychiatry|September 12, 2015
An online programme to reduce depression in patients with multiple sclerosis: a randomised controlled trialAnja Fischer, Johanna Schröder, Eik Vettorazzi, et al.Psychoneuroendocrinology|March 30, 2012
Decreased hydrocortisone sensitivity of T cell function in multiple sclerosis-associated major depressionAnja Fischer, Christian Otte, Thorsten Krieger, et al.Journal of Neurology, Neurosurgery, and Psychiatry|January 15, 2013
Impaired social cognition in multiple sclerosisJana Pöttgen, Isabel Dziobek, Susan Reh, et al.Psychoneuroendocrinology|March 26, 2002
Cognitive impairment correlates with hypothalamo-pituitary-adrenal axis dysregulation in multiple sclerosisChristoph Heesen, Stefan M Gold, Alaleh Raji, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|August 21, 2003
Cognitive impairment in multiple sclerosis does not affect reliability and validity of self-report health measuresStefan M Gold, Holger Schulz, Andrea Mönch, et al.Journal of Neuroimmunology|November 6, 2002
Oral terbutaline differentially affects cytokine (IL-10, IL-12, TNF, IFNg) release in multiple sclerosis patients and controlsChristoph Heesen, Stefan M Gold, Justus Sondermann, et al.Pageof 39